DK0651789T4 - Fremgangsmåde til at forebygge zoster eller lindre varicella-forbundet post-herpetisk neuralgia - Google Patents

Fremgangsmåde til at forebygge zoster eller lindre varicella-forbundet post-herpetisk neuralgia

Info

Publication number
DK0651789T4
DK0651789T4 DK93917150T DK93917150T DK0651789T4 DK 0651789 T4 DK0651789 T4 DK 0651789T4 DK 93917150 T DK93917150 T DK 93917150T DK 93917150 T DK93917150 T DK 93917150T DK 0651789 T4 DK0651789 T4 DK 0651789T4
Authority
DK
Denmark
Prior art keywords
varicella
relieving
herpetic neuralgia
zoster
associated post
Prior art date
Application number
DK93917150T
Other languages
English (en)
Other versions
DK0651789T3 (da
Inventor
Gary B Calandra
Philip J Provost
Myron J Levin
Jo C White
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25435290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0651789(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0651789T3 publication Critical patent/DK0651789T3/da
Publication of DK0651789T4 publication Critical patent/DK0651789T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Exchange Systems With Centralized Control (AREA)
DK93917150T 1992-07-17 1993-07-13 Fremgangsmåde til at forebygge zoster eller lindre varicella-forbundet post-herpetisk neuralgia DK0651789T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91514192A 1992-07-17 1992-07-17
PCT/US1993/006581 WO1994002596A1 (en) 1992-07-17 1993-07-13 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia

Publications (2)

Publication Number Publication Date
DK0651789T3 DK0651789T3 (da) 2002-03-11
DK0651789T4 true DK0651789T4 (da) 2009-07-27

Family

ID=25435290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917150T DK0651789T4 (da) 1992-07-17 1993-07-13 Fremgangsmåde til at forebygge zoster eller lindre varicella-forbundet post-herpetisk neuralgia

Country Status (15)

Country Link
US (2) US5997880A (da)
EP (1) EP0651789B2 (da)
JP (3) JP4562812B2 (da)
AT (1) ATE210722T1 (da)
AU (1) AU687355B2 (da)
CA (1) CA2139515C (da)
CY (1) CY2286B1 (da)
DE (2) DE69331322T3 (da)
DK (1) DK0651789T4 (da)
ES (1) ES2165367T5 (da)
LU (1) LU91287I2 (da)
LV (1) LV12832B (da)
NL (1) NL300246I2 (da)
PT (1) PT651789E (da)
WO (1) WO1994002596A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
JP2011516167A (ja) 2008-04-04 2011-05-26 スリーエム イノベイティブ プロパティズ カンパニー マイクロポンプを有する創傷ドレッシング
UA112970C2 (uk) * 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
US10232035B2 (en) 2012-09-14 2019-03-19 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes virus and use thereof in vaccines
US10350289B2 (en) 2013-09-05 2019-07-16 Merck Sharp & Dohme Corp. Methods of immunization with varicella zoster virus antigen
IL293848B1 (en) 2015-11-06 2024-10-01 Adjuvance Tech Inc Triterpene saponin analogs, methods for their production, preparations containing them and their uses

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US376788A (en) * 1888-01-24 strait
US441737A (en) * 1890-12-02 Tapping-machine for stay-bolt holes
JPS5341202B2 (da) * 1974-03-12 1978-11-01
US4000256A (en) * 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
US4008317A (en) * 1975-12-29 1977-02-15 Recherche Et Industrie Therapeutiques (R.I.T.) Varicella-zoster virus vaccine and preparation thereof
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
EP0101200A3 (en) * 1982-07-20 1985-03-06 BIO-COM Inc. Transfer factor for use in treating viral infections
US4769239A (en) * 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
EP0211756A1 (en) * 1985-08-01 1987-02-25 Merck & Co. Inc. Assay for varicella-zoster virus (VZV) antibodies
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
NZ220645A (en) * 1986-06-20 1989-10-27 Merck & Co Inc Modified varicella-zoster virus and its cultivation
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
EP0405867B1 (en) * 1989-06-27 1995-03-15 SMITHKLINE BEECHAM BIOLOGICALS s.a. Novel compounds
KR920703614A (ko) * 1990-10-04 1992-12-18 티모시 제이. 렉카르트 바리셀라-조스터 바이러스 항원

Also Published As

Publication number Publication date
ES2165367T5 (es) 2009-08-05
DE69331322T2 (de) 2002-08-08
US5997880A (en) 1999-12-07
WO1994002596A1 (en) 1994-02-03
CA2139515C (en) 2008-12-23
LV12832B (en) 2002-09-20
DE122006000063I1 (de) 2007-05-10
EP0651789A4 (en) 1996-06-26
ES2165367T3 (es) 2002-03-16
JP2010189420A (ja) 2010-09-02
LU91287I2 (fr) 2007-01-15
DE69331322D1 (de) 2002-01-24
DE69331322T3 (de) 2009-10-22
AU4676093A (en) 1994-02-14
DK0651789T3 (da) 2002-03-11
PT651789E (pt) 2002-05-31
EP0651789A1 (en) 1995-05-10
EP0651789B2 (en) 2009-05-20
NL300246I2 (nl) 2007-02-01
ATE210722T1 (de) 2001-12-15
US6214354B1 (en) 2001-04-10
JP2004323531A (ja) 2004-11-18
AU687355B2 (en) 1998-02-26
NL300246I1 (nl) 2007-01-02
JPH07509244A (ja) 1995-10-12
CA2139515A1 (en) 1994-02-03
JP4562812B2 (ja) 2010-10-13
LV12832A (en) 2002-05-20
CY2286B1 (en) 2003-07-04
EP0651789B1 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
NL300246I2 (nl) Werkwijze voor het voorkomen van zoster en verlichting van met varicella.
MX9304644A (es) Sistema de concentracion y recoleccion optica que usa reflectores toroidales concavos.
ATE176268T1 (de) Polymerisierbare gelbe farbstoffe sowie ihre verwendung in ophtalmischen linsen
JPS57139705A (en) Optical radiator
NO951212L (no) Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
CA2154780A1 (en) Method for increased sensitivity of radiation detection and measurement
FR1297598A (fr) Projecteur donnant un éclairement pratiquement uniforme sur une surface rectangulaire
Ma'oz et al. The Art and Architecture of the Synagogues of the Golan
US4059755A (en) Luminaire lens insert
ES272064U (es) Disposicion de emision de luz.
ES2150906T3 (es) Antigeno del virus varicella-zoster.
Jablonski et al. NSV 12615-an eclipsing cataclysmic variable with ultrashort period
EP0183215A3 (en) Method for determination of herpes simplex virus antibodies
SU496524A1 (ru) Способ оптического зондировани атмосферы
DE3890362T1 (de) Maskenreparatur unter verwendung eines optimierten fokussierten ionenstrahlsystems
CA2183721A1 (en) Electromagnetic Shutter and Cover
GB1504835A (en) Lighting device for illuminating an air field runway
JPS56116583A (en) Device for reducing radiation of infrared rays from ship
Miller et al. WP Salary Increases Range From 10 to 23 Percent.
Cox et al. SR 45, SCR 23, Permits for Geothermal Development-Statement for Senate Committee on Energy Public Hearing-March 12, 1986
JPS6477035A (en) Automatic illuminance adjusting system
JPS53114448A (en) Optical communication system
Fricke et al. Optical and ultraviolet spectra of Seyfert galaxies
Sundararajan Comment on Professor Johnson’s Article on Computer Language
GB918445A (en) Improvements relating to the prevention of glare